K. Macon

发表

New structural motifs on the chymotrypsin fold and their potential roles in complement factor B

M. Carson, S. Narayana, J. Volanakis, 2000, The EMBO journal.

Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA.

J. Volanakis, T. Horiuchi, V. Kidd, 1990, The Journal of biological chemistry.

Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.

R. Campbell, J. Volanakis, M. Cooper, 1992, The Journal of clinical investigation.

Complement activation by the alternative pathway is modified in renal failure: the role of factor D.

J. Volanakis, J. Paccaud, K. Macon, 1989, Clinical nephrology.

Isolation of complement protein D from urine of patients with Fanconi's syndrome.

J. Volanakis, K. Macon, 1987, Analytical biochemistry.

Major Histocompatibility Complex Class Ill Genes and Susceptibility to Immunoglobulin A Deficiency and Common Variable Immunodeficiency

Schaffer, J. Volanakis, M. Cooper, 2003 .

The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke

L. DeLucas, J. Kappes, G. Tearney, 2017, American journal of respiratory cell and molecular biology.

Secreted Proteases Control Autolysin-mediated Biofilm Growth of Staphylococcus aureus*

S. Narayana, O. Schneewind, Olaf Schneewind, 2013, The Journal of Biological Chemistry.

Structural basis of profactor D activation: from a highly flexible zymogen to a novel self‐inhibited serine protease, complement factor D

L. DeLucas, S. Narayana, J. Volanakis, 1999, The EMBO journal.

The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.

S. Narayana, J. Volanakis, K. Ponnuraj, 2009, Structure.

Structural analysis of engineered Bb fragment of complement factor B: insights into the activation mechanism of the alternative pathway C3-convertase.

S. Narayana, J. Volanakis, K. Ponnuraj, 2004, Molecular cell.

cDNA cloning and characterization of the protein encoded by RD, a gene located in the class III region of the human major histocompatibility complex.

J. Volanakis, K. Macon, J. Cheng, 1993, The Biochemical journal.

A monoclonal antibody which blocks the function of factor D of human complement.

F. Spertini, J. Volanakis, K. Macon, 1990, Journal of immunological methods.

Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions.

S. Narayana, K. Doran, H. Ton-That, 2013, Acta crystallographica. Section D, Biological crystallography.

cDNA cloning and expression of human complement component C2.

J. Volanakis, T. Horiuchi, V. Kidd, 1989, Journal of immunology.

Metabolism of complement factor D in renal failure.

J. Volanakis, J. Schifferli, K. Macon, 1988, Kidney international.

Fcrl5 and T-bet define influenza-specific memory B cells that predict long-lived antibody responses

J. Kearney, Christopher D. Scharer, P. Goepfert, 2019 .

The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

S. Narayana, J. Volanakis, Yuanyuan Xu, 2009, Acta crystallographica. Section D, Biological crystallography.

The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.

S. Narayana, J. Volanakis, Yuanyuan Xu, 2007, Journal of molecular biology.

Recombinant and native zymogen forms of human complement factor D.

J. Volanakis, K. Macon, J. Stevens, 1994, Journal of immunology.

Structure of the human C2 gene.

J. Volanakis, Y. Ishii, K. Macon, 1993, Journal of immunology.

Site-directed mutagenesis of the region around Cys-241 of complement component C2. Evidence for a C4b binding site.

J. Volanakis, J. Engler, T. Horiuchi, 1991, Journal of immunology.

Probing the phosphocholine-binding site of human C-reactive protein by site-directed mutagenesis.

J. Volanakis, A. Agrawal, D. Ansardi, 1992, The Journal of biological chemistry.

B cell and antibody targeting of transplant alloantigen epitopes is supported by both self and allo-recognition

S. Qiu, J. Kearney, E. Saphire, 2023, bioRxiv.